Injection of bone marrow mesenchymal stem cells in the borderline area of infarcted myocardium: Heart status and cell distribution  Hao Zhang, MD, PhD,

Slides:



Advertisements
Similar presentations
Max B. Mitchell, MD  The Journal of Thoracic and Cardiovascular Surgery 
Advertisements

Tracking cardiac engraftment and distribution of implanted bone marrow cells: Comparing intra-aortic, intravenous, and intramyocardial delivery  Shu-Hong.
Lost in translation The Journal of Thoracic and Cardiovascular Surgery
Manuel J. Antunes, MD, PhD, DSc 
A wolf in sheep's clothing
Tracking cardiac engraftment and distribution of implanted bone marrow cells: Comparing intra-aortic, intravenous, and intramyocardial delivery  Shu-Hong.
Expanding options to manage traumatic thoracic vascular injuries
A rare triple threat: Rat bite fever, endocarditis of ventricular septal defect patch, and multivalve endocarditis with sinus of Valsalva fistula  Meena.
The role of methylene blue in serotonin syndrome following cardiac transplantation: A case report and review of the literature  Kendra J. Grubb, MD, Jamie.
Quantitative analysis of survival of transplanted smooth muscle cells with real-time polymerase chain reaction  Tamotsu Yasuda, MD, PhD, Richard D. Weisel,
Tracheal regeneration: Evidence of bone marrow mesenchymal stem cell involvement  Agathe Seguin, MD, PhD, Sonia Baccari, MD, Muriel Holder-Espinasse, MD,
Bone marrow–derived mononuclear cell transplantation improves myocardial recovery by enhancing cellular recruitment and differentiation at the infarction.
Yesterday's heroic measure is now standard procedure: Extracorporeal membrane oxygenation as a bridge to lung transplant  Victor van Berkel, MD, PhD 
Interventional radiology suite or hybrid operating room: Which is the best for lung nodule localization?  Robert B. Cameron, MD  The Journal of Thoracic.
Building a bioartificial heart: A 3-song saga
Ground glass opacity of the lung: The veil that needs lifting
A novel vascularized patch enhances cell survival and modifies ventricular remodeling in a rat myocardial infarction model  Qi Zhou, MD, PhD, Jian-Ye.
Intrinsic cardiac stem cells are essential for regeneration
Centers for Disease Control “increased-risk” organ donor: Not so risky?  Francis D. Pagani, MD, PhD  The Journal of Thoracic and Cardiovascular Surgery 
Form ever follows function
Victor van Berkel, MD, PhD 
Hybrid procedure for the neonatal management of pulmonary atresia with intact ventricular septum  Hao Zhang, MD, PhD, Shou-jun Li, MD, Yong-qing Li, MD,
William M. DeCampli, MD, PhD 
Functional mitral stenosis after mitral valve repair is a true anatomic problem that originates from the time of surgery  Vincent Chan, MD, MPH, Thierry.
Philippe Menasché, MD, PhD 
Intramyocardial injection of tannic acid attenuates postinfarction remodeling: A novel approach to stabilize the breaking extracellular matrix  Hao Zhang,
Calcified amorphous tumor of left atrium
Interstitial tumor-associated macrophages combined with tumor-derived colony- stimulating factor-1 and interleukin-6, a novel prognostic biomarker in non–small.
The first Blalock–Taussig shunt
Surgery for predominant lesion in nonlocalized bronchiectasis
The lord of the rings  Antonio Miceli, MD, PhD 
Sinus node structural changes in patients with long-standing chronic atrial fibrillation  Aquilino Hurlé, MD, PhD, Vicente Climent, MD, PhD, Damian Sánchez-Quintana,
Yang Zhang, MD, Haiquan Chen, MD, PhD 
Aditya K. Kaza, MD  The Journal of Thoracic and Cardiovascular Surgery 
A fairy tale future for Fontans: Fact or fable?
The assessment of cost effectiveness and the effectiveness of cost assessment in cardiothoracic surgery  Vinay Badhwar, MD  The Journal of Thoracic and.
It's not “just a shunt” but sometimes it should be…
The elusive mass in the right atrium: A liver in the heart
Bartley P. Griffith, MD, FACS, FRCS 
Military surgeons just want to have fun
A first start for lung transplantation?
Coronary artery thromboembolism as a result of left ventricular sump aneurysm after congenital heart surgery  Timothy B. Cotts, MD, Felix J. Rogers, DO,
Joseph A. Dearani, MD, Michael J. Ackerman, MD, PhD 
Niv Ad, MD, Lawrence M. Wei, MD 
Fueling the heart: Shifting the myocardial metabolome by targeting endothelial autophagy  Nicholas D. Andersen, MD  The Journal of Thoracic and Cardiovascular.
Is endoluminal vacuum therapy “sponge worthy”?
A fate worse than death  Jennifer S. Lawton, MD 
Internal validation of risk models in lung resection surgery: Bootstrap versus training- and-test sampling  Alessandro Brunelli, MD, Gaetano Rocco, MD 
Video-assisted resection for lung cancer results in fewer complications  Lunxu Liu, PhD, MD, FRCS  The Journal of Thoracic and Cardiovascular Surgery 
Cardiac myxoma: Simplifying a “complex” case
Pathologic correlates of heparin-free donation after cardiac death in lung transplantation  Chase R. Brown, BS, Alexis E. Shafii, MD, Carol F. Farver,
Passing the torch The Journal of Thoracic and Cardiovascular Surgery
Sutureless valve implantation: Every detail counts
T. Brett Reece, MD  The Journal of Thoracic and Cardiovascular Surgery 
The origins of open heart surgery at the University of Minnesota 1951 to 1956  Richard A. DeWall, MD  The Journal of Thoracic and Cardiovascular Surgery 
The Journal of Thoracic and Cardiovascular Surgery
Discussion The Journal of Thoracic and Cardiovascular Surgery
The future of cardiac surgery training: A survival guide
Ventricular assistant in restrictive cardiomyopathy: Making the right connection  Robert D.B. Jaquiss, MD  The Journal of Thoracic and Cardiovascular Surgery 
The continuing challenge of congenital heart disease in China
The Robin Hood principle in the treatment of congenital heart disease: Taking technologic developments intended for adults and using it in kids  Paul.
“The more things change…”: The challenges ahead
Why arch curvature affects arch resistance
Apples remain apples NO matter what
Impact of preoperative left ventricular function and time from infarction on the long-term benefits after intramyocardial CD133+ bone marrow stem cell.
Did you like Terminator 3 better than Terminator 2
Samuel Kim, MD  The Journal of Thoracic and Cardiovascular Surgery 
Journal changes and initiatives
Lessons learned from Melody valve retrieved at transplantation
Deciding how much to pay for effective care
Presentation transcript:

Injection of bone marrow mesenchymal stem cells in the borderline area of infarcted myocardium: Heart status and cell distribution  Hao Zhang, MD, PhD, Peng Song, MD, Yue Tang, MD, PhD, Xiao-ling Zhang, BS, Shi-hua Zhao, MD, Ying-jie Wei, PhD, Sheng-shou Hu, MD  The Journal of Thoracic and Cardiovascular Surgery  Volume 134, Issue 5, Pages 1234-1240.e1 (November 2007) DOI: 10.1016/j.jtcvs.2007.07.019 Copyright © 2007 The American Association for Thoracic Surgery Terms and Conditions

Figure 1 Magnetic resonance visualization of myocardium and the comparison of T2* change in different organs. The dark arrow indicates the signal void corresponding to the injection sites in groups 1 (a) and 2 (b). Group 2 showed weaker signal void than group 1 (c). (T2* change = T2*pre-cell transplant − T2*post-cell transplant). The Journal of Thoracic and Cardiovascular Surgery 2007 134, 1234-1240.e1DOI: (10.1016/j.jtcvs.2007.07.019) Copyright © 2007 The American Association for Thoracic Surgery Terms and Conditions

Figure E1 MRIs of spleen and kidney. The spleen had stronger signal void after cell injection. There was no significant difference in T2* change of the kidney in both groups. Compared with group 1, T2* change of spleen in group 2 was higher. (Arrows represent spleen and stars represent kidney.) The Journal of Thoracic and Cardiovascular Surgery 2007 134, 1234-1240.e1DOI: (10.1016/j.jtcvs.2007.07.019) Copyright © 2007 The American Association for Thoracic Surgery Terms and Conditions

Figure 2 RT-PCR amplification of the transplanted male cell-specific SRY gene in selected sample from different organs after cell transplantation. RT-PCR, Real-time polymerase chain reaction; SRY, Y-chromosome gene. The Journal of Thoracic and Cardiovascular Surgery 2007 134, 1234-1240.e1DOI: (10.1016/j.jtcvs.2007.07.019) Copyright © 2007 The American Association for Thoracic Surgery Terms and Conditions

Figure 3 Identification of the Prussian blue-positive cells in different organs after cell transplantation. The positive cells were mostly localized in the myocardium and spleen. However, more cells could be detected in the myocardial injection sites and fewer cells in the spleen in group 1 (a and c). Fewer positive cells could be found in the liver and lung (e and f). Calprotectin Ab-1 staining showed most of the Prussian blue-positive cells in the heart (g) and spleen (h) had not originated from macrophage. (Black arrow indicated the Prussian blue-positive cells; red arrow indicated the Calprotectin-positive macrophage.) The Journal of Thoracic and Cardiovascular Surgery 2007 134, 1234-1240.e1DOI: (10.1016/j.jtcvs.2007.07.019) Copyright © 2007 The American Association for Thoracic Surgery Terms and Conditions